News 
Market Data 
Discover
FarmaZutical
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CLVLY | Clinuvel Pharmaceuticals | 9.83 | 0.04 | 0.41% | 10/29/2016 | |||||
|
My CLVLY Pitch: Scenesse gives you a good looking tan, it protects you from harmful UV and it is a potent anti inflammatory agent with P53 restoring abilities. This is truly a wonder drug. It's approved in Europe and is currently being made available to EPP patients there. FDA approval is anticipated in 2017.
|
||||||||||
